Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MEDRELEAF CORP T.LEAF

"MedReleaf Corp is engaged in the production and sale of cannabis for medical purposes as regulated by the ACMPR, pursuant to its Licences and, in particular, its Markham Commercial Licence."

TSX:LEAF - Post Discussion

MEDRELEAF CORP > Nanosophere Cannabinoid Delivery System
View:
Post by DrSchwartz on Feb 14, 2018 9:22am

Nanosophere Cannabinoid Delivery System

Check this out. Cannabis companies going to be looking for opportunities like this - ie. Maricann's purchase of nanoleaf. These guys seem more legit and comprehensive. 

https://globenewswire.com/news-release/2018/02/14/1348101/0/en/NanoSphere-Health-Offers-Six-Fold-Improvement-in-Cannabinoid-Bioavailability-CFN-Media.html
Read more at https://www.stockhouse.com/companies/bullboard?symbol=t.weed&postid=27556425#gqjhoVztz3ZzOtdH.99
Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities